Tag Archives: ASND

Top Warren Buffett Stocks To Watch Right Now

I’m sure many of you are familiar with the “desert island” game. You know… the one where someone asks things like:

“If you were stranded on a desert island and could only have one book, what book would that be?” Or maybe… “If you were stranded on a desert island and could only have one album to listen to, what would it be?”

Of course, there are hundreds of variations involving that one thing you would want if you were stranded on a desert island. (Sunscreen.)

I was recently asked, “What’s your desert island indicator?” It’s actually a common question among market analysts because it can provide some interesting insight into how that person thinks, although it became really popular after Warren Buffett was asked about his desert island indicator.

His answer was “railroad car loadings.”

You can always count on Buffett for an interesting answer. Railroads have historically led the business cycle. When demand is picking up, factories will increase their orders, and railroads will increase their delivery of raw materials and finished goods. This should happen near the end of a recession, and the opposite should happen at the beginning of a recession.

Top Warren Buffett Stocks To Watch Right Now: Diebold, Incorporated(DBD)

Advisors’ Opinion:

  • [By Paul Ausick]

    Diebold Nixdorf Inc. (NYSE: DBD) dropped about 25% Friday to set a new 52-week low of $3.55. Shares closed at $4.75 on Thursday, and the stock’s 52-week high is $23.50. Volume totaled around 13 million, about six times the daily average. The company had no specific news.

  • [By Shane Hupp]

    Diebold Nixdorf (NYSE:DBD) was downgraded by equities research analysts at ValuEngine from a “sell” rating to a “strong sell” rating in a report released on Tuesday.

  • [By Dan Caplinger]

    Friday was a poor end to the week on Wall Street, as the Dow Jones Industrial Average lost almost 200 points and other major benchmarks saw similar losses on a percentage basis. A swift turn in relations between the U.S. and NATO partner Turkey was the most popular scapegoat for the decline in market participants’ eyes. Tweets from the U.S. president threatened to double tariffs on steel and aluminum from their already steep levels, marking the latest in a diplomatic row that has shown no signs of easing. Adding to the pressure on stocks was bad news from several individual companies. News Corp. (NASDAQ:NWS) (NASDAQ:NWSA), Diebold Nixdorf (NYSE:DBD), and Dropbox (NASDAQ:DBX) were among the worst performers on the day. Here’s why they did so poorly.

  • [By Max Byerly]

    ILLEGAL ACTIVITY NOTICE: “Diebold Nixdorf (DBD) Bonds Rise 1.3% During Trading” was first posted by Ticker Report and is owned by of Ticker Report. If you are reading this piece of content on another publication, it was illegally stolen and reposted in violation of US and international copyright and trademark legislation. The original version of this piece of content can be viewed at https://www.tickerreport.com/banking-finance/4155454/diebold-nixdorf-dbd-bonds-rise-1-3-during-trading.html.

  • [By Ethan Ryder]

    TRADEMARK VIOLATION NOTICE: “Diebold Nixdorf (DBD) Bonds Trading 2.3% Higher” was published by Ticker Report and is owned by of Ticker Report. If you are viewing this story on another website, it was illegally copied and republished in violation of US & international copyright and trademark laws. The original version of this story can be read at https://www.tickerreport.com/banking-finance/4221845/diebold-nixdorf-dbd-bonds-trading-2-3-higher.html.

Top Warren Buffett Stocks To Watch Right Now: Cable One, Inc.(CABO)

Advisors’ Opinion:

  • [By Ethan Ryder]

    B. Riley set a $860.00 target price on Cable One (NYSE:CABO) in a research report report published on Monday, MarketBeat reports. The firm currently has a buy rating on the stock. B. Riley also issued estimates for Cable One’s FY2019 earnings at $35.69 EPS, FY2020 earnings at $40.47 EPS, FY2021 earnings at $44.98 EPS and FY2022 earnings at $49.01 EPS.

  • [By Stephan Byrd]

    Dynamic Technology Lab Private Ltd bought a new position in Cable One Inc (NYSE:CABO) during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 338 shares of the company’s stock, valued at approximately $247,000.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Cable One (CABO)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    Cable One Inc (NYSE:CABO) major shareholder Donald Graham sold 4,316 shares of the stock in a transaction on Monday, June 11th. The stock was sold at an average price of $662.60, for a total value of $2,859,781.60. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Major shareholders that own more than 10% of a company’s shares are required to disclose their transactions with the SEC.

Top Warren Buffett Stocks To Watch Right Now: Bed Bath & Beyond Inc.(BBBY)

Advisors’ Opinion:

  • [By Dan Caplinger]

    Thursday was generally a positive day on Wall Street, as gains for the Dow Jones Industrial Average reflected new optimism about the U.S. economy. Even with substantial increases in interest rates over the past couple of years from the Federal Reserve, investors have seen few signs that higher financing costs are putting much of a crimp in levels of economic activity. If anything, many companies seem to be thriving from higher rates, especially those in the financial industry. Yet some stocks still weren’t able to participate in the rally. Bed Bath & Beyond (NASDAQ:BBBY), Geron (NASDAQ:GERN), and Canopy Growth (NYSE:CGC) were among the worst performers on the day. Here’s why they did so poorly.

  • [By Garrett Baldwin]

    While researching his best-selling book, “Contrarian Investing,” this man uncovered a method that is surprisingly easy – and less risky than traditional methods of making money in the markets. You can grow incredibly wealthy using this secret method – even when markets are going down. In fact, he made his first huge gain using this method when the markets were completely crashing. See it for yourself…

    Stocks to Watch Today: AMZN, BBBY, BCS, CRM
    Amazon.com Inc. (NASDAQ: AMZN) shares pushed higher after the e-commerce giant received an upgrade from Evercore. The analysts hiked the price target from $1,800 to $1,965 on expectations of higher gross profits. “In this note, we make the case that given Amazon’s shifting business mix,” analysts wrote, “the pace of gross profit growth has become a more relevant indicator of the health of the business, and as such, should be the key metric used to value the company.” Shares of Bed Bath & Beyond Inc. (NASDAQ: BBBY) fell 3.5% after the firm received a stock downgrade from Barclays Plc. (NYSE: BCS). The investment bank said it is concerned about the retail firm’s ongoing restructuring. Barclays dropped its price target for BBBY stock from $15 to $13, citing concerns about retail traffic trends and gross margin growth. Salesforce.com Inc. (NYSE: CRM) will report earnings after the bell on Monday. Look for other earnings reports from YY Inc. (NYSE: YY), Clarus Corp. (NASDAQ: CLAR), and The Children’s Place Inc. (NASDAQ: PLCE).

    Follow Money Morning on Facebook, Twitter, and LinkedIn.

  • [By Chris Hill]

    It’s a bad day to own either Bed Bath & Beyond (NASDAQ:BBBY) or Pier 1 Imports (NYSE:PIR), and the odds of that changing anytime soon aren’t great. BJ’s Wholesale Club popped a whopping 25% from its IPO price, but that doesn’t mean individual investors should get too excited. Madison Square Garden (NYSE:MSG) is thinking about spinning off a few of its sport franchises — a move that could very well achieve the ever-aspirational “unlocking of value.” Press play and find out more.

  • [By Logan Wallace]

    Shares of Bed Bath & Beyond Inc. (NASDAQ:BBBY) gapped down prior to trading on Thursday . The stock had previously closed at $21.54, but opened at $20.18. Bed Bath & Beyond shares last traded at $19.41, with a volume of 15307847 shares changing hands.

  • [By Chris Lange]

    Look for Bed Bath & Beyond Inc. (NYSE: BBBY) to report its most recent quarterly results on Wednesday. Analysts expect to see $0.50 in EPS and $2.96 million in revenue. The shares were changing hands at $19.20 on Friday. The consensus price target is $17.82. The 52-week range is $16.52 to $24.74.

  • [By Dan Caplinger]

    The stock market got off to a slow start to the week on Monday, with major benchmarks mostly falling. As we’ve seen repeatedly in recent months, trade concerns were at the top of the list for nervous investors, and it’s unclear to many whether the tactics that the Trump administration is using are meant to be mere negotiating levers or permanent measures with the intent of evening the playing field for international commerce. Regardless, some individual stocks had good showings despite the market’s choppiness. Bed Bath & Beyond (NASDAQ:BBBY), Frontier Communications (NASDAQ:FTR), and Neptune Technologies & Bioressources (NASDAQ:NEPT) were among the best performers on the day. Here’s why they did so well.

Top Warren Buffett Stocks To Watch Right Now: Federal Agricultural Mortgage Corporation(AGM)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Here are some of the headlines that may have impacted Accern’s rankings:

    Get Federal Agricultural Mortgage alerts:

    Zacks: Federal Agricultural Mortgage Co. (AGM) Given Average Rating of “Strong Buy” by Analysts (americanbankingnews.com) Federal Agricultural Mortgage Co. (AGM) Announces $0.58 Quarterly Dividend (americanbankingnews.com) Federal Agricultural Mortgage Corporation: Farmer Mac Declares Dividends and Announces Conference Call for First Quarter 2018 Results (twst.com) Federal Agricultural Mortgage (AGM) Set to Announce Earnings on Tuesday (americanbankingnews.com)

    Federal Agricultural Mortgage stock opened at $87.14 on Monday. The company has a market capitalization of $925.08, a PE ratio of 14.17 and a beta of 1.18. Federal Agricultural Mortgage has a twelve month low of $54.51 and a twelve month high of $92.57. The company has a quick ratio of 0.37, a current ratio of 0.37 and a debt-to-equity ratio of 2.87.

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Federal Agricultural Mortgage Corp. Class C (AGM)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    Media headlines about Federal Agricultural Mortgage Corp. Class C (NYSE:AGM) have been trending positive recently, according to Accern Sentiment. The research firm identifies negative and positive media coverage by monitoring more than twenty million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. Federal Agricultural Mortgage Corp. Class C earned a news sentiment score of 0.27 on Accern’s scale. Accern also gave media stories about the credit services provider an impact score of 46.6079928540378 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the near future.

  • [By Logan Wallace]

    Boston Advisors LLC acquired a new stake in Federal Agricultural Mortgage Corp. Class C (NYSE:AGM) in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 42,148 shares of the credit services provider’s stock, valued at approximately $3,771,000.

Top Warren Buffett Stocks To Watch Right Now: Ascendis Pharma A/S(ASND)

Advisors’ Opinion:

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Ascendis Pharma (ASND)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Cory Renauer]

    Shares of Ascendis Pharma (NASDAQ:ASND), a biopharmaceutical company committed to extended-release technology, are soaring after the company released pivotal trial results for its lead candidate. Investors expecting blockbuster sales have pushed the stock 58.8% higher as of 12:04 p.m. EST on Monday. 

  • [By ]

    There was also a mixed bag of other suggestions — Rashmi Kwatra, the founder of Sixteenth Street Capital, liked Brac Bank, which is listed on the Dhaka stock market in Bangladesh. It is the 12th largest bank in Bangladesh, but the most profitable with the highest credit rating. John Khoury of Long Point Capital LP sees a 50% upside at homebuilder D.R. Horton (DHI)  and Oleg Nodelman likes U.S. biotech firm Ascendis Pharma. (ASND)

  • [By Dan Caplinger]

    The stock market lost ground on Monday, as investors appeared to have second thoughts about the future of the U.S. economy even as trade negotiations with China appear to be going well. The Dow Jones Industrial Average had been down by more than 400 points earlier in the session before recovering to finish lower by just 207, and broader benchmarks saw more modest declines on a percentage basis. Even amid the carnage, there was some good news for certain companies. Washington Real Estate Investment Trust (NYSE:WRE), Ascendis Pharma (NASDAQ:ASND), and Bluegreen Vacations (NYSE:BXG) were among the top performers. Here’s why they did so well.

Top 5 Heal Care Stocks To Invest In 2019

Kraton (NYSE: KRA) and Eastman Chemical (NYSE:EMN) are both basic materials companies, but which is the better business? We will compare the two companies based on the strength of their dividends, institutional ownership, profitability, earnings, analyst recommendations, valuation and risk.

Dividends

Get Kraton alerts:

Eastman Chemical pays an annual dividend of $2.24 per share and has a dividend yield of 2.1%. Kraton does not pay a dividend. Eastman Chemical pays out 29.4% of its earnings in the form of a dividend. Eastman Chemical has raised its dividend for 6 consecutive years.

Institutional and Insider Ownership

97.3% of Kraton shares are held by institutional investors. Comparatively, 83.9% of Eastman Chemical shares are held by institutional investors. 4.7% of Kraton shares are held by insiders. Comparatively, 1.1% of Eastman Chemical shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Top 5 Heal Care Stocks To Invest In 2019: Ascendis Pharma A/S(ASND)

Advisors’ Opinion:

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Ascendis Pharma (ASND)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Chris Lange]

    Ascendis Pharma A/S (NASDAQ: ASND) is expected to present full Phase 1 data from its TransCon-PTH hypoparathyroidism treatment later this month. Shares of Ascendis closed Friday at $66.52, with a consensus analyst target price of $84.66 and a 52-week trading range of $25.50 to $76.29.

  • [By Chris Lange]

    Ascendis Pharma A/S (NASDAQ: ASND) is expected to present full Phase 1 data from its TransCon-PTH hypoparathyroidism treatment later this month. Shares of Ascendis closed Friday at $66.78, with a consensus analyst target of $80.17 and a 52-week range of $22.25 to $76.29.

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Ascendis Pharma A/S (ASND)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    Ascendis Pharma (NASDAQ:ASND) saw some unusual options trading activity on Monday. Investors purchased 1,979 call options on the stock. This is an increase of approximately 1,377% compared to the typical volume of 134 call options.

  • [By ]

    There was also a mixed bag of other suggestions — Rashmi Kwatra, the founder of Sixteenth Street Capital, liked Brac Bank, which is listed on the Dhaka stock market in Bangladesh. It is the 12th largest bank in Bangladesh, but the most profitable with the highest credit rating. John Khoury of Long Point Capital LP sees a 50% upside at homebuilder D.R. Horton (DHI)  and Oleg Nodelman likes U.S. biotech firm Ascendis Pharma. (ASND)

Top 5 Heal Care Stocks To Invest In 2019: Brainstorm Cell Therapeutics Inc.(BCLI)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Axovant Sciences Ltd. (NASDAQ: AXON) shares rose 23.7 percent to $1.49. Axovant announced strengthening of management team and completion of organization restructuring which "enhanced capabilities in research and business development" and reduced internal headcount by 43 percent.
    Mammoth Energy Services, Inc. (NASDAQ: TUSK) shares jumped 19.8 percent to $37.3148. Mammoth Energy’s subsidiary Cobra signed a new $900 million contract to finish the restoration of critical electrical services and support the initial phase of reconstruction of the electrical utility system in Puerto Rico.
    Acorn International, Inc. (NYSE: ATV) shares gained 19 percent to $34.0201. Acorn shares rose Friday after the company declared a special one-time cash dividend of $14.97 per ADS.
    DHI Group, Inc. (NYSE: DHX) shares surged 19 percent to $2.20.
    My Size, Inc. (NASDAQ: MYSZ) climbed 16.8 percent to $1.18 after the company received a Notice of Allowance from the USPTO for measurement technology patent.
    Global Eagle Entertainment Inc. (NASDAQ: ENT) gained 16.6 percent to $2.32.
    Leju Holdings Limited (NYSE: LEJU) gained 16.5 percent to $1.34 following Q1 beat.
    Evolus, Inc. (NASDAQ: EOLS) shares surged 16.5 percent to $26.1499. Evolus named Lauren Silvernail as Chief Financial Officer and Executive Vice President, Corporate Development.
    Jupai Holdings Limited (NYSE: JP) shares gained 15 percent to $26.29 after reporting Q1 results.
    Momo Inc. (NASDAQ: MOMO) shares gained 15 percent to $44.7702 after the company reported better-than-expected results for its first quarter and issued strong sales forecast for the second quarter.
    Windstream Holdings, Inc. (NASDAQ: WIN) rose 15 percent to $7.075.
    China Advanced Construction Materials Group, Inc. (NASDAQ: CADC) gained 14.4 percent to $2.746.
    American Woodmark Corporation (NASDAQ: AMWD) climbed 14.2 percent to $101.10 after the company reported upbeat Q4 results.
    Savara Inc. (NAS
  • [By Lisa Levin] Companies Reporting Before The Bell
    Hanwha Q CELLS Co., Ltd. (NASDAQ: HQCL) is estimated to report quarterly earnings at $0.14 per share on revenue of $438.40 million.
    Remark Holdings, Inc. (NASDAQ: MARK) is projected to report quarterly loss at $0.35 per share on revenue of $19.45 million.
    Athenex, Inc. (NYSE: ATNX) is expected to report quarterly loss at $0.07 per share on revenue of $35.14 million.
    Mazor Robotics Ltd. (NASDAQ: MZOR) is estimated to report quarterly loss at $0.08 per share on revenue of $15.14 million.
    Brainstorm Cell Therapeutics Inc. (NASDAQ: BCLI) is projected to report a quarterly loss at $0.14 per share.
    SuperCom Ltd. (NASDAQ: SPCB) is expected to report quarterly earnings at $0.08 per share on revenue of $9.50 million.
    Lonestar Resources US Inc. (NASDAQ: LONE) is projected to report quarterly loss at $0.04 per share on revenue of $30.68 million.
    Nine Energy Service, Inc. (NASDAQ: NINE) is estimated to report quarterly earnings at $0.1 per share on revenue of $165.76 million.
    VEON Ltd. (NASDAQ: VEON) is projected to report quarterly earnings at $0.05 per share on revenue of $212.00 million.

     

  • [By Stephan Byrd]

    Brainstorm Cell Therapeutics (NASDAQ:BCLI) is scheduled to announce its earnings results before the market opens on Monday, July 23rd.

    Brainstorm Cell Therapeutics (NASDAQ:BCLI) last announced its earnings results on Monday, May 14th. The biotechnology company reported ($0.12) EPS for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.14) by $0.02. On average, analysts expect Brainstorm Cell Therapeutics to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year.

  • [By Logan Wallace]

    Maxim Group set a $9.00 target price on Brainstorm Cell Therapeutics (NASDAQ:BCLI) in a research note issued to investors on Monday morning. The brokerage currently has a buy rating on the biotechnology company’s stock.

Top 5 Heal Care Stocks To Invest In 2019: Jupai Holdings Limited(JP)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    TransEnterix, Inc. (NYSE: TRXC) rose 28.8 percent to $4.03 in pre-market trading after the company disclosed that it has received the FDA clearance for expanded indications for its Senhance Surgical System.
    Global Eagle Entertainment Inc. (NASDAQ: ENT) rose 15.6 percent to $2.30 in pre-market trading.
    Companhia Brasileira de Distribuição (NYSE: CBD) rose 13.2 percent to $24.20 in pre-market trading.
    ZTO Express (Cayman) Inc. (NYSE: ZTO) rose 12.2 percent to $21.65 in pre-market trading. Alibaba and Cainiao agreed to make strategic investment in ZTO Express of $1.38 billion.
    DHI Group, Inc. (NYSE: DHX) rose 10.8 percent to $2.05 in pre-market trading.
    Momo Inc. (NASDAQ: MOMO) shares rose 9.6 percent to $42.68 in pre-market trading after the company reported better-than-expected results for its first quarter and issued strong sales forecast for the second quarter.
    Xenon Pharmaceuticals Inc. (NASDAQ: XENE) shares rose 9.1 percent to $6.00 in pre-market trading.
    Universal Display Corporation (NASDAQ: OLED) rose 8.4 percent to $108.00 in pre-market trading.
    Jupai Holdings Limited (NYSE: JP) shares rose 7 percent to $24.50 in pre-market trading after reporting Q1 results.
    Net 1 UEPS Technologies, Inc. (NASDAQ: UEPS) rose 5.9 percent to $10.61 in pre-market trading.
    Frontline Ltd. (NYSE: FRO) rose 5.9 percent to $5.04 in pre-market trading.
    Evogene Ltd. (NASDAQ: EVGN) rose 5.5 percent to $3.27 in pre-market trading after reporting Q1 results.
    Sears Holdings Corporation (NASDAQ: SHLD) rose 5.5 percent to $3.68 in pre-market trading after gaining 5.44 percent on Friday.
    Kitov Pharma Ltd (NASDAQ: KTOV) shares rose 5.4 percent to $2.16 in pre-market trading.

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

  • [By Lisa Levin] Gainers
    Axovant Sciences Ltd. (NASDAQ: AXON) shares rose 23.7 percent to $1.49. Axovant announced strengthening of management team and completion of organization restructuring which "enhanced capabilities in research and business development" and reduced internal headcount by 43 percent.
    Mammoth Energy Services, Inc. (NASDAQ: TUSK) shares jumped 19.8 percent to $37.3148. Mammoth Energy’s subsidiary Cobra signed a new $900 million contract to finish the restoration of critical electrical services and support the initial phase of reconstruction of the electrical utility system in Puerto Rico.
    Acorn International, Inc. (NYSE: ATV) shares gained 19 percent to $34.0201. Acorn shares rose Friday after the company declared a special one-time cash dividend of $14.97 per ADS.
    DHI Group, Inc. (NYSE: DHX) shares surged 19 percent to $2.20.
    My Size, Inc. (NASDAQ: MYSZ) climbed 16.8 percent to $1.18 after the company received a Notice of Allowance from the USPTO for measurement technology patent.
    Global Eagle Entertainment Inc. (NASDAQ: ENT) gained 16.6 percent to $2.32.
    Leju Holdings Limited (NYSE: LEJU) gained 16.5 percent to $1.34 following Q1 beat.
    Evolus, Inc. (NASDAQ: EOLS) shares surged 16.5 percent to $26.1499. Evolus named Lauren Silvernail as Chief Financial Officer and Executive Vice President, Corporate Development.
    Jupai Holdings Limited (NYSE: JP) shares gained 15 percent to $26.29 after reporting Q1 results.
    Momo Inc. (NASDAQ: MOMO) shares gained 15 percent to $44.7702 after the company reported better-than-expected results for its first quarter and issued strong sales forecast for the second quarter.
    Windstream Holdings, Inc. (NASDAQ: WIN) rose 15 percent to $7.075.
    China Advanced Construction Materials Group, Inc. (NASDAQ: CADC) gained 14.4 percent to $2.746.
    American Woodmark Corporation (NASDAQ: AMWD) climbed 14.2 percent to $101.10 after the company reported upbeat Q4 results.
    Savara Inc. (NAS
  • [By Lisa Levin]

    Jupai Holdings Limited (NYSE: JP) shares shot up 16 percent to $26.48 after reporting Q1 results.

    Shares of American Woodmark Corporation (NASDAQ: AMWD) got a boost, shooting up 13 percent to $100.05 after the company reported upbeat Q4 results.

  • [By Lisa Levin]

    On Tuesday, the financial shares surged 0.71 percent. Meanwhile, top gainers in the sector included Guaranty Bancorp (NASDAQ: GBNK), up 5 percent, and Jupai Holdings Limited (NYSE: JP) up 5 percent.

Top 5 Heal Care Stocks To Invest In 2019: Nuveen Massachusetts Premium Income Municipal Fund(NMT)

Advisors’ Opinion:

  • [By Joseph Griffin]

    News articles about Nuveen Massachusetts Pre Income Mun Fd (NYSE:NMT) have been trending somewhat positive this week, according to Accern Sentiment Analysis. The research group ranks the sentiment of media coverage by analyzing more than twenty million news and blog sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Nuveen Massachusetts Pre Income Mun Fd earned a daily sentiment score of 0.16 on Accern’s scale. Accern also assigned news stories about the financial services provider an impact score of 47.5987310031013 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the immediate future.

Top 5 Heal Care Stocks To Invest In 2019: Farmers National Banc Corp.(FMNB)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Farmers National Banc (NASDAQ:FMNB)‘s stock had its “hold” rating reissued by equities researchers at Keefe, Bruyette & Woods in a note issued to investors on Thursday. They presently have a $18.00 price target on the bank’s stock. Keefe, Bruyette & Woods’ price target would indicate a potential upside of 21.62% from the company’s previous close.

Hot Undervalued Stocks For 2019

Shares of Amicus Therapeutics (FOLD) have come a long way since I originally presented the idea as “undervalued with catalysts” at the end of 2016. In total I’ve written four update pieces since and the stock has continued to be a decent performer.

Figure 1: FOLD daily advanced chart (Source: Finviz Elite) (Disclosure: Contains affiliate link)

In premarket today, the stock is in the red by a bit over 2% on news that the company sold 19,354,839 shares at a price point of $15.50 per share. Gross proceeds are expected to total around $300 million. Underwriter option is for an additional 2,903,225 shares should it be exercised. Dilution of around 13% or so appears acceptable, and it’s worth noting that JPMorgan and Goldman Sachs are serving as joint lead book-running managers while Cowen and Leerink Partners are acting as co-booking managers (Bank of America Merrill Lynch as lead co-manager). This type of investment banking participation bodes well, as does pricing which is at only a slight discount to the current share price. Keep in mind that the deal was originally for $250 million but then it was upsized to $300 million, another bullish sign.

Hot Undervalued Stocks For 2019: ABAXIS Inc.(ABAX)

Advisors’ Opinion:

  • [By Lisa Levin]

    Abaxis, Inc. (NASDAQ: ABAX) shares were also up, gaining 16 percent to $82.95. Zoetis Inc. (NYSE: ZTS) announced plans to acquire Abaxis for $83 per share in cash.

  • [By Logan Wallace]

    TRADEMARK VIOLATION NOTICE: “Brokerages Expect Abaxis (ABAX) Will Post Earnings of $0.32 Per Share” was posted by Ticker Report and is the sole property of of Ticker Report. If you are reading this news story on another domain, it was illegally copied and republished in violation of U.S. & international copyright and trademark legislation. The original version of this news story can be read at https://www.tickerreport.com/banking-finance/3373644/brokerages-expect-abaxis-abax-will-post-earnings-of-0-32-per-share.html.

  • [By Lisa Levin]

    Abaxis, Inc. (NASDAQ: ABAX) shares were also up, gaining 15 percent to $82.75. Zoetis Inc. (NYSE: ZTS) announced plans to acquire Abaxis for $83 per share in cash.

Hot Undervalued Stocks For 2019: Ascendis Pharma A/S(ASND)

Advisors’ Opinion:

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Ascendis Pharma (ASND)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By ]

    There was also a mixed bag of other suggestions — Rashmi Kwatra, the founder of Sixteenth Street Capital, liked Brac Bank, which is listed on the Dhaka stock market in Bangladesh. It is the 12th largest bank in Bangladesh, but the most profitable with the highest credit rating. John Khoury of Long Point Capital LP sees a 50% upside at homebuilder D.R. Horton (DHI)  and Oleg Nodelman likes U.S. biotech firm Ascendis Pharma. (ASND)

  • [By Logan Wallace]

    Ascendis Pharma (NASDAQ:ASND) saw some unusual options trading activity on Monday. Investors purchased 1,979 call options on the stock. This is an increase of approximately 1,377% compared to the typical volume of 134 call options.

Hot Undervalued Stocks For 2019: Peoples Bancorp Inc.(PEBO)

Advisors’ Opinion:

  • [By Joseph Griffin]

    BidaskClub downgraded shares of Peoples Bancorp (NASDAQ:PEBO) from a strong-buy rating to a buy rating in a report released on Friday.

    Several other equities analysts have also recently issued reports on PEBO. Boenning Scattergood reissued a hold rating on shares of Peoples Bancorp in a research note on Wednesday, April 25th. Hovde Group set a $39.00 price objective on shares of Peoples Bancorp and gave the company a hold rating in a research note on Tuesday, April 24th. Zacks Investment Research raised shares of Peoples Bancorp from a hold rating to a buy rating and set a $37.00 price objective on the stock in a research note on Wednesday, January 10th. ValuEngine raised shares of Peoples Bancorp from a hold rating to a buy rating in a research note on Tuesday, April 24th. Finally, Sandler O’Neill reissued a hold rating and issued a $37.00 price objective on shares of Peoples Bancorp in a research note on Tuesday, January 23rd. Five investment analysts have rated the stock with a hold rating and two have issued a buy rating to the company’s stock. Peoples Bancorp has a consensus rating of Hold and a consensus target price of $38.00.

Hot Undervalued Stocks For 2019: Vishay Intertechnology, Inc.(VSH)

Advisors’ Opinion:

  • [By Max Byerly]

    Mercury Systems (NASDAQ: MRCY) and Vishay Intertechnology (NYSE:VSH) are both computer and technology companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, valuation, analyst recommendations, profitability, risk, earnings and institutional ownership.

Hot Undervalued Stocks For 2019: Chesapeake Energy Corporation(CHK)

Advisors’ Opinion:

  • [By Paul Ausick]

    Chesapeake Energy Corp. (NYSE: CHK) dropped about 4.6% Friday to match a 52-week low of $3.30 after closing at $3.46 on Thursday. The stock’s 52-week high is $6.65. Volume was around 35 million, about 25% above the daily average of around 28.8 million. The company had no specific news.

  • [By Paul Ausick]

    Chesapeake Energy Corp. (NYSE: CHK) dropped more than 10% Friday to post a new 52-week low of $2.53 after closing at $2.82 on Thursday. The stock’s 52-week high is $6.59. Volume was around 55 million, almost double the daily average of about 30 million. The company had no specific news, but tumbling oil & natural gas prices simply punish this stock.

  • [By Paul Ausick]

    Here’s how share prices of the largest U.S. natural gas producers reacted to today’s report:

    Exxon Mobil Corp. (NYSE: XOM), the country’s largest producer of natural gas, traded up about 0.1% to $74.35, in a 52-week range of $73.56 to $89.30. Chesapeake Energy Corp. (NYSE: CHK) traded down about 0.7%, at $3.02 in a 52-week range of $2.53 to $6.59. EOG Resources Inc. (NYSE: EOG) traded down about 0.7% to $100.14. The 52-week range is $81.99 to $119.00.

    Furthermore, the United States Natural Gas ETF (NYSEARCA: UNG) traded down about 1.1%, at $22.96 in a 52-week range of $20.40 to $31.72.

  • [By Paul Ausick]

    Here’s how share prices of the largest U.S. natural gas producers reacting to the latest report:

    Exxon Mobil Corp. (NYSE: XOM), the country’s largest producer of natural gas, traded up less than 0.1% to $79.26, in a 52-week range of $72.16 to $89.30. Chesapeake Energy Corp. (NYSE: CHK) traded down about 2%, at $3.07 in a 52-week range of $2.53 to $5.87. EOG Resources Inc. (NYSE: EOG) traded up about 0.8% to $113.76. The 52-week range is $81.99 to $119.00.

    Furthermore, the United States Natural Gas ETF (NYSEARCA: UNG) traded down about 0.9%, at $22.41 in a 52-week range of $20.40 to $31.72.

$300,000.00 in Sales Expected for Ascendis Pharma (ASND) This Quarter

Equities research analysts expect that Ascendis Pharma (NASDAQ:ASND) will post sales of $300,000.00 for the current quarter, according to Zacks Investment Research. Two analysts have provided estimates for Ascendis Pharma’s earnings. The highest sales estimate is $340,000.00 and the lowest is $250,000.00. Ascendis Pharma reported sales of $400,000.00 in the same quarter last year, which indicates a negative year-over-year growth rate of 25%. The company is scheduled to issue its next quarterly earnings results on Tuesday, May 22nd.

According to Zacks, analysts expect that Ascendis Pharma will report full-year sales of $2.44 million for the current year, with estimates ranging from $980,000.00 to $6.00 million. For the next year, analysts forecast that the business will report sales of $53.92 million per share, with estimates ranging from $1.38 million to $159.00 million. Zacks’ sales averages are an average based on a survey of sell-side research firms that follow Ascendis Pharma.

Get Ascendis Pharma alerts:

Ascendis Pharma (NASDAQ:ASND) last released its quarterly earnings data on Wednesday, March 28th. The biotechnology company reported ($1.08) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.92) by ($0.16). Ascendis Pharma had a negative net margin of 8,156.09% and a negative return on equity of 74.67%. The firm had revenue of $0.33 million for the quarter, compared to the consensus estimate of $0.58 million.

A number of analysts have weighed in on the company. HC Wainwright reiterated a “buy” rating on shares of Ascendis Pharma in a research report on Friday, January 19th. Wedbush reiterated a “top pick” rating and issued a $76.00 price target on shares of Ascendis Pharma in a research report on Friday, April 20th. JPMorgan Chase reiterated a “buy” rating and issued a $60.00 price target on shares of Ascendis Pharma in a research report on Wednesday, January 17th. Credit Suisse Group reiterated a “buy” rating and issued a $50.00 price target on shares of Ascendis Pharma in a research report on Sunday, February 25th. Finally, Zacks Investment Research upgraded Ascendis Pharma from a “strong sell” rating to a “hold” rating in a research report on Wednesday, February 21st. Two investment analysts have rated the stock with a hold rating, five have issued a buy rating and three have assigned a strong buy rating to the stock. Ascendis Pharma currently has an average rating of “Buy” and an average target price of $67.33.

NASDAQ:ASND traded up $0.38 during trading hours on Wednesday, reaching $65.50. The company had a trading volume of 223,700 shares, compared to its average volume of 168,850. Ascendis Pharma has a one year low of $65.88 and a one year high of $66.99.

Institutional investors have recently bought and sold shares of the business. Atria Investments LLC acquired a new position in Ascendis Pharma in the first quarter worth $212,000. Quantbot Technologies LP acquired a new position in Ascendis Pharma in the first quarter worth $215,000. JPMorgan Chase & Co. acquired a new position in Ascendis Pharma in the first quarter worth $255,000. Quantitative Systematic Strategies LLC acquired a new position in Ascendis Pharma in the fourth quarter worth $269,000. Finally, Flinton Capital Management LLC acquired a new position in Ascendis Pharma in the first quarter worth $295,000. 73.64% of the stock is currently owned by institutional investors.

Ascendis Pharma Company Profile

Ascendis Pharma A/S, a clinical stage biopharmaceutical company, develops various prodrug therapies for unmet medical needs. The company develops TransCon human growth hormone, which is in Phase III clinical study in children to treat growth hormone deficiency; TransCon parathyroid hormone that is in Phase I clinical study for treating hypoparathyroidism; and TransCon C-type natriuretic peptide for the treatment of achondroplasia.

Get a free copy of the Zacks research report on Ascendis Pharma (ASND)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Ascendis Pharma (NASDAQ:ASND)